Aprecia Partners with Apprentice.io to Scale AI-Powered 3D Pharmaceutical Manufacturing
核心洞察
Aprecia (搜索), the industry leader in pharmaceutical 3D printing, has partnered with Apprentice.io (搜索) to implement AI-powered manufacturing technology at its Ohio facility.
The collaboration combines cutting-edge artificial intelligence with breakthrough 3D printing innovation to accelerate production workflows and ensure consistent execution at scale.
Apprentice.io (搜索)'s cloud-native platform provides no-code integration tools and digital manufacturing capabilities designed to support rapid deployment across multiple production sites.
Aprecia (搜索), the pharmaceutical industry's leading three-dimensional printing company, has announced a strategic partnership with Apprentice.io (搜索) to implement AI-powered manufacturing technology at its Ohio facility. The collaboration marks a significant advancement in digitally connected drug manufacturing, combining artificial intelligence with breakthrough 3D printing innovation in drug delivery solutions.
AI Integration Transforms Manufacturing Workflows
Through this partnership, Aprecia (搜索) will deploy Apprentice.io (搜索)'s intelligent manufacturing platform to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration directly supports Aprecia's mission to revolutionize medication production and delivery using advanced additive manufacturing techniques.
Apprentice.io (搜索)'s cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide the flexibility, scalability, and connectivity required for Aprecia (搜索)'s manufacturing model. As the company continues to expand, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.
"I believe that Aprecia (搜索) is the next generation of additive manufacturing," said Angelo Stracquatanio (搜索), CEO & Co-founder of Apprentice.io (搜索). "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."
Advancing Precision Drug Delivery
The deployment of Apprentice's technology reflects both companies' shared commitment to next-level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.
Kyle Smith (搜索), President and Chief Operating Officer at Aprecia (搜索), emphasized the partnership's strategic importance: "Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation. Our partnership with Apprentice.io (搜索) strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."
Manufacturing Innovation Leadership
Aprecia (搜索) has established itself as a pioneer in pharmaceutical manufacturing through advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Located in Mason, Ohio, the company's capabilities encompass pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods.
For over 20 years, Aprecia (搜索) has led pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option while continuously exploring ways to improve medicine and patient health outcomes. Through strategic partnerships, the company creates personalized medicine solutions and accelerates market entry, setting new industry standards.
Apprentice.io (搜索) represents the industry's first agentic manufacturing platform built for modern pharmaceutical production beyond traditional paper-based and legacy manufacturing execution systems. The platform unifies manufacturing execution systems, laboratory execution systems, automation, and remote collaboration capabilities in a modern, no-code environment while deploying AI agents to support every manufacturing step.